Company

Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech
Clinical trial approval / initiationmRNA

Walvax Initiates Phase I Trial of Lyophilized Shingles mRNA Vaccine – First‑in‑Class Herpes Zoster Candidate Co‑Developed with Fudan University and RQ Biotech

Walvax Biotechnology Co., Ltd. (SHE: 300142) announced the official initiation of a Phase I clinical trial of its lyophilized herpes zoster (shingles) mRNA vaccine, co‑developed with Fudan University and RQ…

Keymed Biosciences' Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%

Keymed Biosciences’ Stapokibart Wins Fourth NMPA Indication – Adolescent Atopic Dermatitis Approval as Kangyueda Revenue Surges 227%

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems

ChemPartner and BioBAY Open Arsenal Innovation Center in Massachusetts – Bridging Suzhou and Boston Life Science Ecosystems

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Regeneron Secures FDA Approval for Otarmeni Gene Therapy and Announces Landmark U.S. Pricing Agreement
Gene therapyNASDAQ: REGN

Regeneron Secures FDA Approval for Otarmeni Gene Therapy and Announces Landmark U.S. Pricing Agreement

Thermo Fisher Scientific Reports 6% Revenue Growth in Q1 2026 Driven by Innovative Product Launches and Strategic AI Collaboration
Finanical ReportsNYSE: TMO

Thermo Fisher Scientific Reports 6% Revenue Growth in Q1 2026 Driven by Innovative Product Launches and Strategic AI Collaboration

HKG: 6600HKG: 6618

SciClone Pharmaceuticals Partners with JD Healthcare to Pioneer Integrated Immune Health Management Model

Roche Q1 Sales Rise 6% Driven by Innovative Medicines as China Expansion and Diagnostics Recovery Offset Currency Headwinds
BiosimilarsCancer

Roche Q1 Sales Rise 6% Driven by Innovative Medicines as China Expansion and Diagnostics Recovery Offset Currency Headwinds

Show More